首页> 美国卫生研究院文献>Molecules >Heterocycles h-Fused Onto 4-Oxoquinoline-3-Carboxylic Acid Part VIII 1. Convenient Synthesis and Antimicrobial Properties of Substituted Hexahydro14diazepino23-hquinoline-9-carboxylic acid and Its Tetrahydroquino78-bbenzodiazepine Analog
【2h】

Heterocycles h-Fused Onto 4-Oxoquinoline-3-Carboxylic Acid Part VIII 1. Convenient Synthesis and Antimicrobial Properties of Substituted Hexahydro14diazepino23-hquinoline-9-carboxylic acid and Its Tetrahydroquino78-bbenzodiazepine Analog

机译:杂环h-融合到4-氧喹啉-3-羧酸上第VIII部分1。取代的六氢14二氮杂23-h喹啉-9-羧酸及其四氢喹78-b苯并二氮杂Analog类似物的简便合成及抗菌性能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

[1,4]Diazepino[2,3-h]quinolone carboxylic acid >3 and its benzo-homolog tetrahydroquino[7,8-b]benzodiazepine-3-carboxylic acid >5 were prepared via PPA-catalyzed thermal lactamization of the respective 8-amino-7-substituted-1,4-dihydro-quinoline-3-carboxylic acid derivatives >8, >10. The latter compounds were obtained by reduction of their 8-nitro-7-substituted-1,4-dihydroquinoline-3-carboxylic acid precursors >7, >9 which, in turn, were prepared by reaction of 7-chloro-1-cyclopropyl-6-fluoro-8-nitro-1,4-dihydroquinoline-3-carboxylic acid (>6) with each of β-alanine and anthranilic acid. All intermediates and target compounds were characterized using elemental analysis, NMR, IR and MS spectral data. The prepared targets and the intermediates have shown interesting antibacterial activity mainly against Gram positive strains. In particular, compound >8 showed good activity against S. aureus (MIC = 0.39 µg/mL) and B. subtilis (MIC = 0.78 µg/mL). Compounds >5a and >9 have also displayed good antifungal activity against C. albicans (MIC = 1.56 µg/mL and 0.78 µg/mL, respectively). None of the compounds tested showed any anticancer activity against solid breast cancer cell line MCF-7 cells or a human breast adenocarcinoma cell line.
机译:[1,4]重氮庚并[2,3-h]喹诺酮羧酸> 3 及其苯并同源四氢喹[7,8-b]苯并二氮杂-3-羧酸> 5 分别通过PPA催化的8-氨基-7-取代的1,,4-二氢喹啉-3-羧酸衍生物> 8 ,> 10 的内酰胺化制备。后者的化合物是通过还原其8-硝基-7-取代的1,4-二氢喹啉-3-羧酸前体> 7 ,> 9 而获得的,通过7-氯-1-环丙基-6-氟-8-硝基-1,4-二氢喹啉-3-羧酸(> 6 )与β-丙氨酸和邻氨基苯甲酸的反应制备。使用元素分析,NMR,IR和MS光谱数据对所有中间体和目标化合物进行了表征。制备的靶标和中间体已显示出有趣的主要针对革兰氏阳性菌株的抗菌活性。特别是化合物> 8 对金黄色葡萄球菌(MIC = 0.39 µg / mL)和枯草芽孢杆菌(MIC = 0.78 µg / mL)表现出良好的活性。化合物> 5a 和> 9 对白念珠菌也显示出良好的抗真菌活性(MIC分别为1.56 µg / mL和0.78 µg / mL)。测试的化合物均未显示出对固体乳腺癌细胞系MCF-7细胞或人乳腺癌细胞系的任何抗癌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号